Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Matthew Greenhawt to Markov Chains

This is a "connection" page, showing publications Matthew Greenhawt has written about Markov Chains.

 
Connection Strength
 
 
 
1.167
 
  1. Shaker MS, Oppenheimer J, Rider NL, Golden DBK, Anagnostou A, Greenhawt M. A health economic analysis of noninjectable epinephrine compared with intramuscular epinephrine. Ann Allergy Asthma Immunol. 2025 May; 134(5):587-593.e1.
    View in: PubMed
    Score: 0.228
  2. Shaker M, Anagnostou A, Abrams EM, Lee M, Conway AE, Hsu Blatman KS, Oppenheimer J, Greenhawt M. The Cost-Effectiveness of Omalizumab for Treatment of Food Allergy. J Allergy Clin Immunol Pract. 2024 Sep; 12(9):2481-2489.e1.
    View in: PubMed
    Score: 0.221
  3. Shaker MS, Mosnaim G, Oppenheimer J, Stukus D, Abrams EM, Greenhawt M. Health and Economic Outcomes of Home Maintenance Allergen Immunotherapy in Select Patients with High Health Literacy during the COVID-19 Pandemic: A Cost-Effectiveness Analysis During Exceptional Times. J Allergy Clin Immunol Pract. 2020 Jul - Aug; 8(7):2310-2321.e4.
    View in: PubMed
    Score: 0.166
  4. Shaker MS, Greenhawt MJ. Analysis of Value-Based Costs of Undesignated School Stock Epinephrine Policies for Peanut Anaphylaxis. JAMA Pediatr. 2019 02 01; 173(2):169-175.
    View in: PubMed
    Score: 0.152
  5. Shaker M, Verma K, Greenhawt M. The health and economic outcomes of early egg introduction strategies. Allergy. 2018 11; 73(11):2214-2223.
    View in: PubMed
    Score: 0.150
  6. Shaker M, Stukus D, Chan ES, Fleischer DM, Spergel JM, Greenhawt M. "To screen or not to screen": Comparing the health and economic benefits of early peanut introduction strategies in five countries. Allergy. 2018 Aug; 73(8):1707-1714.
    View in: PubMed
    Score: 0.145
  7. Lloyd M, Morton JI, Peters RL, Loke P, Ashley S, Shaker MS, Greenhawt M, Ademi Z, Tang MLK. Cost-Effectiveness of Oral Immunotherapy for Egg Allergy According to Age of Therapy Commencement. J Allergy Clin Immunol Pract. 2025 Mar; 13(3):619-629.
    View in: PubMed
    Score: 0.057
  8. Sun D, Heimall JR, Greenhawt MJ, Bunin NJ, Shaker MS, Romberg N. Cost Utility of Lifelong Immunoglobulin Replacement Therapy vs Hematopoietic Stem Cell Transplant to Treat Agammaglobulinemia. JAMA Pediatr. 2022 02 01; 176(2):176-184.
    View in: PubMed
    Score: 0.047
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)